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 1 
ABSTRACT 2 
 3 
Porphyromonas gingivalis, a gram negative anaerobe, which is implicated in the 4 
etiology of active periodontitis, secretes degradative enzymes (gingipains) and 5 
sheds proinflammatory mediators (e.g. lipopolysaccharides; LPS). LPS triggers 6 
the secretion of interleukin-8 from immune (IL-8-72) and non-immune (IL-8-77) 7 
cells. IL-8-77 has low chemotactic and respiratory burst-inducing activity but is 8 
susceptible to cleavage by gingipains. This study shows that both R- and K-9 
gingipain treatments of IL-8-77 significantly enhance burst-activation by fMLP 10 
and chemotactic activity (p<0.05), but decrease burst-activation and the 11 
chemotactic activity of IL-8-72 towards neutrophil-like HL-60 cells and primary 12 
neutrophils (p<0.05). Using MS/MS we have demonstrated that R-gingipain 13 
cleaves 5 and 11 amino acid peptides from the N-terminal of IL-8-77, and 14 
resultant peptides are biologically active, whilst K-gingipain removes an 8 amino 15 
acid N-terminal peptide yielding a 69 amino acid isoform of IL-8 which shows 16 
enhanced biological activity. During periodontitis, secreted gingipains may 17 
differentially affect neutrophil chemotaxis and activation in response to IL-8 18 
according to the cellular source of the chemokine. 19 
 20 
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INTRODUCTION 1 
 2 
Inflammatory periodontal diseases have an infectious aetiology and are 3 
characterised by excess inflammation within the periodontal tissues, which can 4 
progress to alveolar bone loss and ultimately tooth loss (4). The primary 5 
aetiological agent for  periodontitis is the subgingival plaque biofilm and disease 6 
progression is associated with an ecological shift in biofilm composition to a 7 
predominantly anaerobic flora (5, 27). Evidence indicates that this in turn triggers 8 
the host response, which in susceptible patients is abnormal, involving excess 9 
generation of proteolytic enzymes (9) and reactive oxygen species (ROS; (18)) 10 
both of which are important determinants of disease progression and severity (5, 11 
11).  Neutrophilic inflammation is the major source of the tissue destructive 12 
species (6) and recent studies have demonstrated that peripheral blood 13 
neutrophils from periodontitis patients are both hyper-reactive to Fcγ-receptor 14 
stimulation and also demonstrate baseline hyper-activity, with respect to 15 
extracellular ROS release (17, 18).  The extracellular ROS production from 16 
neutrophil infiltrates into the periodontium is significant (17) but modest, however, 17 
any process which results in enhanced polymorphonuclear leukocyte recruitment 18 
to, or retention (e.g. delayed apoptosis) within the periodontal tissues may 19 
contribute to ROS-mediated tissue damage. 20 
 21 
The oral anaerobic rod, Porphyromonas gingivalis, is the organism most strongly 22 
associated with active periodontitis (1). This organism possesses a number of 23 
 5 
virulence determinants which potentially contribute to its pathogenicity including 1 
the ability to secrete a range of degradative proteinases (1); among  these, the 2 
gingipains have been extensively studied (15). Furthermore, the pathogenic 3 
bacteria within the subgingival environment shed proinflammatory mediators 4 
such as lipopolysaccharide (LPS). LPS in turn triggers the secretion of 5 
chemokines/cytokines such as IL-1β, TNF-α, IL-6 and interleukin-8 (IL-8-72) from 6 
resident inflammatory cells, which contribute to the initial inflammatory response 7 
(20).  8 
 9 
IL-8 is a major chemokine with potent stimulatory effects on neutrophils including 10 
chemotaxis, degranulation, and cytoplasmic Ca2+ elevation.  IL-8 is a small 11 
polypeptide with a molecular weight of 8-10kD (22) that was originally isolated 12 
from monocytes (2). Subsequent studies have shown that IL-8 is also produced 13 
from a wide range of cell types including fibroblasts, epithelial cells/keratinocytes, 14 
lymphocytes, endothelial cells and neutrophilic polymorphonuclear leukocytes 15 
(neutrophils). In response to  stimulus, IL-8 is produced as a 99 amino acid long 16 
precursor polypeptide (2), which is subsequently processed into a biologically 17 
active peptide. IL-8 varies in length from 79 amino acids through to 77, 72, 71, 70 18 
and 69 amino acid variants (23). Although IL-8 is subject to variable processing 19 
at the N-terminus, the 72 amino acid long (IL-8-72) and 77 amino acid long (IL-8-20 
77) peptides have been identified as the predominant variants.  The major form 21 
of IL-8-72 has been extensively studied for its potent ability to prime neutrophils 22 
to stimulate the respiratory burst to a secondary stimulus, such as fMLP (12, 14).  23 
 24 
 6 
IL-8-77 is recognised as a less potent variant for neutrophil activation. It exhibits 1 
reduced chemotactic properties and attenuates neutrophil adhesion to 2 
endothelial cell walls (10). Recent reports have suggested that this longer amino 3 
acid form is susceptible to cleavage by proteolysis into a biologically active form 4 
(13, 24, 25). It has also been shown that IL-8-77 is susceptible to cleavage by 5 
gingipains, the principal secreted cysteine proteases of P.gingivalis (19).  The 6 
potential for gingipains to enhance the activity of IL-8-77, presents an additional 7 
mechanism of the organism’s pathogenicity, whereby P.gingivalis promotes 8 
enhanced neutrophil recruitment, activation and further local tissue degradation. 9 
To date the effect of gingipain processing of IL-8 on subsequent chemotactic 10 
activity or respiratory burst priming has not been determined. Therefore, this 11 
report investigates whether gingipains from P. gingivalis can modify IL-8-77 12 
chemotactic and priming activities using primary neutrophils and differentiated 13 
neutrophil-like HL-60 cell line as responder cells.  14 
 15 
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 24 
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MATERIALS AND METHODS 1 
 2 
Materials. P.gingivalis W83 was kindly provided by Dr. A. Roberts (Periodontal 3 
Research Group, School of Dentistry, University of Birmingham, U.K.). All 4 
reagents were obtained from Sigma Chemical Company (Poole, U.K.) and 5 
solvents from Fisher (Loughborough, U.K.) unless otherwise stated. RPMI 1640, 6 
foetal bovine serum and penicillin (1000 U ml-1)/ streptomycin (10,000 µg ml-1) 7 
were obtained from GibcoBRL (Paisley, U.K.). Recombinant IL-8-72 endothelial 8 
derived recombinant IL-8-77 and monoclonal anti-human IL-8 antibody, clone 9 
6218,  were purchased from R&D systems (Abingdon, U.K.).  10 
 11 
HL60 cell cultures. The human pro-myelocytic cell line HL60 was purchased 12 
from the European collection of cell cultures (ECACC no 98070101) and 13 
maintained in RPMI-1640 medium supplemented with 10% heat inactivated foetal 14 
calf serum (FCS) and 1% penicillin/streptomycin at 370C in a 5% CO2/ 95% air 15 
humidified atmosphere. The cells were induced to differentiate in the presence of 16 
1.0% dimethyl sulfoxide (DMSO) for 5 days after seeding at cell density of 2 ×105 17 
cells/ml.  18 
 19 
Collection and isolation of peripheral blood Neutrophils. Venous blood was 20 
collected from systemically and periodontally healthy donors into 4% sodium 21 
citrate (w/v) in PBS, with a ratio of citrate:blood of 1:9  and neutrophils were 22 
isolated as described in Matthews et al 2007 (7). Isolated cells were washed and 23 
resuspended in physiological salt solution (PSS: 115mM NaCl, 5mM KCl, 1mM 24 
 8 
KH2PO4, 10mM glucose, 1mM MgSO4, 1.25mM CaCl2, 25mM Hepes-Na 1 
supplemented with 0.1% bovine serum albumin (BSA) at pH 7.4). 2 
 3 
Cultivation of Porphyromonas gingivalis Strain W83. Cultures were grown 4 
statically in 200ml of liquid medium containing 6.0g of trypticase soy broth (Difco, 5 
Detroit, Mich, U.S.A), 2.0 g of yeast extract, supplemented with 1mg of hemin, 6 
200mg of L-cysteine, 20mg of di-thiothreitol and 0.5mg of menadione at 370C in 7 
an anaerobic atmosphere of 10% H2, 10% CO2, and 80% N2 for 48h (miniMACS 8 
anaerobic workstation, Don Whitley Scientific). 9 
 10 
Isolation of Arg(R)-gingipain and Lys (K)-gingipain. Gingipains were isolated 11 
according to the method described in Yun et al 1999 (29) using a 5ml packed 12 
volume arginine-sepharose column for the final affinity purification stage. Column 13 
fractions (1ml) containing Kgp (eluted with 0.75M L-lysine) and Rgp (eluted with 14 
1M L-arginine) were dialysed against Tris buffer overnight at 5oC. 15 
 16 
Enzyme activity assays. The amidolytic activities of the purified Rgp and Kgp 17 
were measured with the substrate Nα-benzoyl-L-arginine p-nitroanilide 18 
hydrochloride (L-BAPNA). 100µl of Rgp and Kgp fractions were incubated with L-19 
BAPNA (final concentration of 1mM) in 100µl of 0.2M Tris-HCl, 0.1M NaCl, 5mM 20 
CaCl2, 10mM L-cysteine at pH 7.6 and 370C. After one-hour incubation, the 21 
reaction was stopped by addition of 10µl of glacial acetic acid. The optical density 22 
 9 
was measured at 405nm for each fraction and the values corrected by 1 
subtraction of negative control values (without proteinases).  2 
 3 
Proteolytic degradation of IL-8 by purified gingipains. Pooled fractions for 4 
each gingipain were activated as described in Mikolajczyk-Pawlinska et al (18). 5 
Rgp and Kgp were adjusted to equimolar concentrations in Tris buffer, pH7.6. 6 
Activated gingipains (3mM) were mixed with 1.65µM IL-8-77 or IL-8-72 and 7 
incubated at 37oC for 30min. Enzyme activity was terminated post-incubation by 8 
addition of 1 µl of a protease inhibitor cocktail containing leupeptin hemisulphate. 9 
 10 
MS/MS analysis of Kgp and Rgp treated IL-8-77 and IL-8-72. Kgp or Rgp 11 
treated IL-8-77 and IL-8-72 (0.14pg/µl) was diluted in 50% methanol in water with 12 
acetic acid (1%) to enhance ionisation and subjected to mass analysis after 13 
injection at 1µl/ min using a Thermo LTQ MS/MS in electrospray mode. The 14 
machine was externally mass-calibrated using peptides, caffeine and Ultramark 15 
1621TM (ABCR GmbH & Co.). The acceleration voltage was set at 20 kV and 16 
data was collected as the average total scan of 100 scans with the scan range 17 
set from 100-2000 m/z to search for fragmented IL-8-77 and IL-8-72. Multiply 18 
charged molecular ions were subjected to collision-induced dissociation (CID) 19 
with argon gas and the resulting MS/MS data were recorded for comparison 20 
against SWISSPROT predicted cleavage sites in IL-8 21 
 22 
 10 
Neutralisation of IL-8-77 peptide chemotactic activity. In order to investigate 1 
whether the enhanced biological activity of Kgp or Rgp treated IL-8 could be 2 
ascribed to the resultant formation of IL-8-72 rather than to the released peptides, 3 
neutralising anti-human IL-8 antibody (5µg/ml) which recognises the whole 4 
molecule, was added into Kgp or Rgp treated IL-8-77 (8.25nM) for 30 min at 5 
room temperature prior to addition of neutralised IL-8 to the lower chambers for 6 
chemotaxis experiments. 7 
 8 
 9 
Chemotaxis assay. dHL60 cell/neutrophil chemotaxis was measured by 10 
Boyden’s technique using (2µm or 5µm pore size respectively) PVP-free 11 
polycarbonate filters in 96 multiwell chamber (Neuroprobe Inc.). dHL60 12 
cells/neutrophils (1 × 105) were washed and re-suspended in PSS. Pre- and post-13 
gingipain-treated IL-8 (8.25nM) samples, gingipain treated and antibody 14 
neutralised IL-8-77 and untreated gingipains were added to the lower wells of the 15 
chamber, the filter was fixed in place and upper wells were loaded with 1 × 105 16 
dHL-60 cells/neutrophils in 100µl of PSS at 37oC for 90 minutes. After 17 
chemotaxis, cell-containing buffer from the upper chamber was removed and the 18 
top of the filter was washed with PSS. The microplate/filter assembly was 19 
centrifuged at 400g for 10min. The filter was carefully removed and cell counts in 20 
the lower chamber were taken by flow cytometry (Coulter Epics XL). Results 21 
were expressed as specific cell migration after subtraction of background 22 
migration. Escherichia Coli LPS (serotype 0111:B4, 1µg/ml) was used as a 23 
 11 
positive control in all assays and Rgp and Kgp alone in the presence of protease 1 
inhibitor cocktail acted as a negative control. 2 
 3 
Chemiluminescent assay for respiratory burst activity. Chemiluminescence 4 
assays were performed using lucigenin to detect total superoxide production by 5 
neutrophils or dHL60 cells. Assays were performed (37°C) using a Berthold 6 
microplate luminometer (LB96v). Neutrophils (5 ×105 cells) were added to each 7 
well containing 100µM lucigenin in PSS and incubated for 30 min at 37°C. Li ght 8 
emission in relative light units (RLUs) was recorded during the 30-min pre-9 
stimulation period to established steady baseline. Cells were then incubated with 10 
gingipain-treated or untreated IL-8 isoforms for 10 min prior to stimulation with 11 
1µM fMLP. The RLU peak values were analysed for each treatment, and time to 12 
peak for each stimulus was recorded. 13 
 14 
Data analysis. Statistical analysis was performed by one-way ANOVA followed 15 
by Tukey’s comparison test analysis. A  P< 0.05 was considered as significant. 16 
17 
 12 
RESULTS 1 
 2 
Kgp and Rgp specifically cleave the N-terminus of IL-8-77. Rgp has two 3 
theoretical, amino peptidase cleavage sites for IL-8-77 and Kgp has three amino 4 
peptidase cleavage sites in IL-8-77 (Fig 1). At the N-terminus of IL-8-72, Rgp has 5 
one theoretical cleavage site whilst Kgp has three sites.  To investigate the 6 
effects of gingipain activity on IL-8-77, released N-terminal peptides 7 
corresponding in mass to Rgp and Kgp cleaved IL-8-77 isoforms were 8 
investigated by MS/MS with CID. Rgp treatments preferentially cleaved the N-9 
terminus of IL-8-77 releasing peptides of m/z 555.7 and 703.82 corresponding to 10 
residues 1-5 and 6-11 of the N-terminal region with the sequences reported in 11 
Table 1, to produce 72 and 66 amino acid long IL-8 peptides. Rgp treatment also 12 
released a peptide of m/z 703.41 and sequence SAKELR from IL-8-72 to yield an 13 
IL-8-66 polypeptide. However, Kgp treatment of IL-8-77 released an 8 amino acid 14 
long polypeptide of 842.03 m/z (AVLPRSAK) from the N-terminus resulting in a 15 
69 amino acid long IL-8 polypeptide. Kgp treatment of IL-8-72 released peptides 16 
of 305.18, 1135.4 and 498.5 m/z resulting in 69, 61 and 57 amino acid long 17 
peptides respectively.  18 
 19 
Kgp and Rgp increase the chemotactic properties of biologically inactive 20 
IL-8-77. In order to determine the effect of Rgp and Kgp treatment on 21 
chemotactic properties of IL-8 isoforms, dHL60 cells/ primary neutrophils were 22 
allowed to undergo chemotaxis towards pre- or post-gingipain treated IL-8-72 23 
and IL-8-77 isoforms. The effect of gingipain treatment in IL-8-dependent 24 
 13 
chemotaxis was corrected for chemotaxis towards either inactivated Rgp or 1 
inactivated Kgp, where migration was always lower towards gingipains than to 2 
LPS or IL-8 isoforms. IL-8-72 demonstrated higher chemotactic activity than the 3 
native IL-8-77 isoform. Both Rgp (Fig. 2A) and Kgp (Fig. 2B) treatments 4 
significantly decreased the chemotactic activity of IL-8-72 (P<0.001) towards 5 
HL60 cells. In contrast, Kgp treatment significantly increased IL-8-77 chemotactic 6 
properties (P<0.05). In order to compare the behaviour of dHL60 cells with 7 
peripheral blood neutrophils, chemotaxis of primary neutrophils towards IL-8 8 
isoforms was measured. Confirming the observations in dHL60 cells, both Kgp- 9 
(Fig. 2C) and Rgp- (Fig. 2D) treatments significantly increased the chemotactic 10 
properties of IL-8-77 (p<0.001 and p<0.01 respectively) towards primary 11 
neutrophils.  12 
 13 
N-terminal-shortened peptide fragments of IL-8-77 account for the 14 
increased chemotactic activity. To investigate whether N-terminal-shortened 15 
IL-8-77 peptides accounted for the observed chemotactic activity, gingipain-16 
treated IL-8-77 was neutralised with anti-human IL-8 antibody prior to chemotaxis 17 
assay.  Both antibody-neutralised Rgp-treated IL-8-77 (Fig 3A) and Kgp-treated 18 
IL-8-77 (Fig 3B) showed significantly decreased chemotactic activity towards 19 
dHL60 cells (p<0.05 and p<0.01 respectively) when compared with gingipain-20 
treated IL-8-77 in the absence of neutralising antibody. Similarly, when the 21 
experiment was repeated using neutralised Kgp- or Rgp-treated IL-8-77 as a 22 
chemotaxin for neutrophils, again, the enhanced biological activity of gingipain-23 
cleaved IL-8-77 was not evident (Fig 3C and 3D). 24 
 14 
 1 
Kgp and Rgp increase the priming effect of IL-8-77 for the respiratory burst 2 
in response to fMLP. The priming effect of IL-8 on the fMLP-induced respiratory 3 
burst was measured by lucigenin-dependant chemiluminescence using isolated 4 
peripheral blood neutrophils. IL-8-72 primed neutrophils for enhanced superoxide 5 
production after fMLP stimulation whereas neither IL-8-77 nor isolated gingipains 6 
had any priming effect (Fig. 4).  However, both Rgp- (Fig. 4A) and Kgp- (Fig. 4B) 7 
treated IL-8-77 primed neutrophils for fMLP induced superoxide production, 8 
demonstrating significantly increased superoxide generation compared with 9 
native IL-8-77 (p<0.05).  By contrast, gingipain treatment decreased the priming 10 
activity of IL-8-72 (p<0.05) for fMLP-stimulated superoxide production.  11 
 12 
DISCUSSION 13 
 14 
Infection of host tissue by pathogenic bacteria and/or stimulation by microbial 15 
components/virulence factors triggers the production of pro-inflammatory 16 
peptides that have the ability to activate and recruit neutrophilic 17 
polymorphonuclear leucocytes along a concentration gradient. Patients with 18 
periodontitis show increased numbers of neutrophils within periodontal tissues 19 
and pockets (21), and recent work has demonstrated baseline hyper-activity of 20 
peripheral blood neutrophils, with respect to extracellular ROS release (18) and 21 
proteolytic enzyme release (9), in periodontitis patients relative to matched 22 
healthy controls.  Such mechanisms when co-active may explain a significant 23 
amount of the oxidative stress reported in periodontitis tissues (6). Therefore the 24 
 15 
influence of periodontal bacteria and their virulence factors on IL-8-mediated 1 
neutrophil chemotaxis and activation are important to elucidate.  In contrast to 2 
biologically active IL-8-72, the IL-8-77 peptide produced by epithelial cells, 3 
fibroblasts and endothelial cells is resistant to a wide range of host proteinases; it 4 
has a low chemotactic activity (10) and less respiratory burst priming activity. In 5 
our experiments, we have used LPS as a positive control; LPS is a well known 6 
chemotactic bacterial component which requires serum components such as 7 
LPS-binding protein for receptor activation (28). However, as serum may also 8 
contain other chemotactic factors, it was excluded from our experiments, and the 9 
chemotactic activity of LPS in serum-free conditions here was greater than IL-8-10 
77 but less than IL-8-72 towards primary neutrophils. 11 
 12 
In this study we have investigated a possible mechanism by which P.gingivalis 13 
could manipulate IL-8 cytokine-mediated neutrophil chemotaxis using a dHL60 14 
cell model and also primary human neutrophils. Gingipains increased the priming 15 
activity induced by IL-8-77 on the fMLP-induced oxidative burst in primary 16 
neutrophils, data that confirms previous studies measuring elastase release from 17 
neutrophils, where IL-8-77-induced release was shown to be increased after 18 
gingipain treatment (19). 19 
 20 
Our results demonstrate a significant increase in the chemotactic properties of IL-21 
8-77 and a higher priming capability of IL-8-77 after incubation with L-cysteine-22 
activated gingipains under the conditions described. Compared with primary 23 
neutrophils, dHL60 cells have low CXC2 receptor expression (26), and this may 24 
 16 
explain the lower rate of dHL60 cell migration towards IL-8. The corresponding 1 
increase in data variation may account for the lack of significant increase in 2 
migration of dHL60 towards Rgp-treated IL-8-77 when compared to the increased 3 
migration of primary neutrophils. Chemotactic properties and priming abilities of 4 
truncated, gingipain-treated forms of IL-8-77 were found to be 2-3-fold higher 5 
compared with non-treated IL-8-77. Using a neutralising antibody against the 6 
complete sequence of IL-8, we confirmed that the increased biological activity of 7 
IL-8-77 following gingipain treatment was due to the release of mature IL-8 rather 8 
than due to the release of small peptides identified by MS, as the neutralizing 9 
antibody (which does not recognize small peptide fragments) completely inhibited 10 
the increase in activity. Given that reported concentrations of reduced 11 
glutathione/cysteine in gingival fluids are 1000-fold higher than those of serum 12 
(7), this may represent a physiologically relevant mechanism whereby gingipains 13 
contribute to neutrophil recruitment and activation at P. gingivalis infected sites.  14 
 15 
The extended amino terminus of IL-8-77 folds back to interact with the essential 16 
Glu4-Leu5-Arg6 (ELR) sequence; this may protect the ELR from interaction with 17 
the receptor and may explain the low chemotactic activity of IL-8-77 compared to 18 
IL-8-72. The N-terminal amino acid sequence of IL-8-77 is 19 
AVLPRSAKELRCQCIKTYSK- [21]. Rgp has theoretical, specific amino-peptidase 20 
cleavage activity at Arg5-Ser6 and Arg11-Cys12 [15] yielding peptides of 72 and 66 21 
amino acid lengths. After Rgp treatment, we observed cleavage products of IL-8-22 
77 by MS/MS of the 5 and 11 amino acids corresponding to the putative N-23 
terminal cleavage sites. There was no evidence of low molecular weight peptides 24 
 17 
corresponding to cleavage at the putative C-terminal sites. Even though some 1 
reports suggest that ELR in IL-8 are necessary for high affinity binding to IL-8 2 
receptor, recent studies have shown that IL-8-(66) has similar activity to IL-8-72 3 
(8). Our observations do not fully support this later work; whilst an increase in 4 
activity of IL-8-77 is observed after Rgp treatment which results in products of 72 5 
and 66 amino acid length, a decrease in IL-8-72 activity was observed after Rgp 6 
treatment, indicating that IL-8-66 is not biologically active and that the observed 7 
increase in activity after treatment of IL-8-77 with Rgp may be due to release of 8 
IL-8-72 alone. Active IL-8 requires a properly folded protein structure with a 9 
highly conserved ELR sequence near the N-terminus that is critical for its activity 10 
(16). Kgp, with its specificity for the Lys-X peptide bond, is predicted to cleave the 11 
IL-8-77 amino terminal sequence at Lys8-Glu9, and this product was observed in 12 
our studies by MS/MS. The resultant 69 amino acid long form of IL-8 shows 13 
enhanced biological activity compared with IL-8-77 in our studies of chemotactic 14 
activity and respiratory burst priming. In contrast, the more biologically active 15 
form of IL-8-72 showed reduced chemotactic activity after treatment with both 16 
Rgp and Kgp. Analysis of released peptides by MS/MS confirmed further 17 
cleavage of IL-8-72 releasing three peptides corresponding to the 15 N-terminal 18 
amino acids of IL-8-72. The presence of five amino acids at the N- terminus of IL-19 
8-77 compared to IL-8-72 appears to modulate cleavage of the peptide by 20 
gingipains. The difference in IL-8-77 susceptibility to gingipain treatment 21 
compared with IL-8-72 may relate to either differences in three dimensional 22 
structures at the N-terminus or specific charge differences which contribute to 23 
change in altered accessibility and thus cleavage by gingipains.  Previous studies 24 
 18 
have shown that prolonged incubation with Rgp or Kgp could result total IL-8-77 1 
degradation (19); physiologically, a concentration gradient will exist, where 2 
released gingipain will be highest in closest proximity to the site of bacterial 3 
colonization and via diffusion, the concentration of gingipains will be lower further 4 
away from the site. Thus, whilst initial enzyme release may activate local IL-8-77 5 
in the early stages of infection, the IL-8-77 may be completely degraded in the 6 
immediate locality over time. However, further from the site of infection, diffusing 7 
gingipain may cause activation of local IL-8-77. The importance of this 8 
observation should be addressed in vivo following specific inhibition of gingipain 9 
activity or expression. 10 
 11 
Previous studies have shown that the capacity of gingipains to manipulate the 12 
host cytokine network is partly due to degradation of other cytokines such as IL-13 
1β, IL-6, and TNF-α (3) .Therefore, it has been suggested that the ability to 14 
inactivate cytokines by P.gingivalis in the early stages of pathogenesis is 15 
advantageous for the organism. Rgp has recently been shown to digest secretory 16 
leukocyte protease inhibitor (SLPI) released from neutrophils thus reducing the 17 
protective effect against bacterial pro-inflammatory molecules by which disease 18 
in periodontal tissues may be accelerated [21]. In contrast, degradation of pro-19 
inflammatory cytokines could diminish neutrophil chemotaxis towards infected 20 
periodontal sites by lowering inflammatory cytokine secretion. However, in 21 
periodontal patients, neutrophil recruitment to the gingival crevice is maintained 22 
despite the presence of gingipains.  23 
 24 
 19 
It is probable that an alternative mechanism exists to promote neutrophil 1 
chemotaxis and activity at periodontitis sites which may involve the secretion of 2 
the longer form of IL-8-77 by non-immune cells. This in vitro study provides a 3 
possible mechanism for P.gingivalis manipulated neutrophil chemotaxis into 4 
periodontal pockets via activation of IL-8-77 as illustrated by figure 5. In 5 
conclusion, products from P. gingivalis may regulate host neutrophil 6 
accumulation at infected periodontal sites by initially stimulating the production of 7 
IL-8-77 by non-immune cells (e.g. epithelium) and promoting gingipain-8 
dependent modification of IL-8-77 into a more biologically active chemokine 9 
which promotes neutrophil chemotaxis and priming.  Thereafter, after prolonged 10 
degradation by gingipains, the modified IL-8-77 may reduce chemotaxis and 11 
neutrophil priming, thus prolonging the inflammatory lesion.  Such a model (figure 12 
5) is worthy of further investigation. 13 
14 
 20 
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TABLE 1 1 
Gingipain treatment of IL-8-77 and IL-8-72 released several amino terminal 2 
peptides as determined by MS/MS. The table documents peptide mass to charge 3 
(m/z) ratios, amino acid positions and sequences of peptides released post-Kgp 4 
treatment of IL-8-77. 5 
 6 
 7 
8 
IL-8 
isoform 
Gingipain 
treatment 
m/z Start End Sequence 
 
IL-8-77 
Rgp 555.7020 1 5 AVLPR 
 703.8212 6 11 SAKELR 
Kgp 842.0352 1 8 AVLPRSAK 
IL-8-72 
Rgp 
 
703.4097 
 
1 6 SAKELR 
Kgp 
 
 
305.1819 
1135.4 
498.5 
1 
4 
12 
3 
11 
15 
SAK 
ELRCQCIK 
TYSK 
 27 
FIGURE LEGENDS 1 
FIG. 1. N-terminal amino acid sequence of IL-8 and possible Rgp and Kgp 2 
cleavage sites. IL-8-77 has a five amino acid extended peptide sequence to IL-3 
8-72. Rgp has specific amino peptidase activity to R-X peptide bonds and Kgp 4 
has specific amino peptidase activity to K-X peptide bonds. 5 
 6 
FIG. 2. Gingipain treatment increases chemotactic activity of IL-8-77 7 
towards dHL60 cells and neutrophils.  IL-8 isoforms of 72 and 77 amino acid 8 
long peptides were treated with 10mM cysteine activated Kgp or Rgp for 30 min. 9 
Chemotaxis (corrected for background) of 1×105 dHL60 cells through a 2µm filter 10 
towards Kgp (A) and Rgp (B) treated or untreated IL-8 isoforms was observed for 11 
90 min in a multiwell chemotaxis chamber. Specific chemotaxis of 1×105 primary 12 
neutrophils towards Kgp (C) and Rgp (D) treated IL-8 isoforms through a 5µm 13 
filter was observed for 90 min in multiwell chemotaxis chamber. Cell counts in the 14 
lower wells were taken by flow cytometry and are expressed as mean cell 15 
number migrated ± S.E.M, where n=3 independent experiments performed in 16 
triplicate. * p<0.01, ** p<0.001 and NS = not significant using Tukey’s multiple 17 
comparison test. 18 
 19 
FIG. 3. Major IL-8 peptides released from gingipain treatment of IL-8-77 are 20 
responsible for enhanced chemotactic activity of dHL60 cells and primary 21 
neutrophils.  IL-8 isoforms of 72 and 77 amino acid long peptides were treated 22 
with 10mM cysteine activated Kgp or Rgp for 30 min. After neutralisation of 23 
gingipains, resultant peptides were subsequently incubated with neutralising anti-24 
 28 
IL-8. Chemotaxis (corrected for background) of 1×105 dHL60 cells through a 2µm 1 
filter towards Kgp-treated-IL-8-77  and Kgp-treated-IL-8-77  + IL-8 neutralised 2 
isoforms (A) or Rgp-treated-IL-8-77  and Rgp-treated-IL-8-77  + IL-8 neutralised 3 
isoforms (B) was observed for 90 min in a multiwell chemotaxis chamber. 4 
Specific chemotaxis of 1×105 primary neutrophils towards Kgp-treated-IL-8-77 5 
and Kgp-treated-IL-8-77  + IL-8 neutralised isoforms (C) and Rgp-treated-IL-8-77  6 
and Rgp-treated-IL-8-77  + IL-8 neutralised isoforms (D) through a 5µm filter was 7 
observed for 90 min in a multiwell chemotaxis chamber. Cell counts in the lower 8 
wells were taken by flow cytometry and are expressed as mean cell number 9 
migrated ± S.E.M, where n=3 independent experiments performed in triplicate. ** 10 
p<0.001 using Tukey’s multiple comparison test. 11 
 12 
FIG. 4. Gingipain treatment enhances the priming effect of IL-8-77 on 13 
neutrophils. Neutrophils (5×105) were primed with (a) Rgp-treated or untreated 14 
IL-8 isoforms or (B) Kgp- treated or untreated IL-8 isoforms for 10min prior to 15 
stimulation with 1µM fMLP. Mean peak (RLU± S.E.M., n=9) chemiluminescence 16 
generated by neutrophils was recorded. Significant differences were calculated (* 17 
p<0.05) using Tukey’s multiple comparison test. NS= not significant . 18 
 19 
Fig. 5: Schematic representation of gingipain modulated IL-8 response. Pg 20 
stimulates production of host pro-inflammatory mediators including IL-8. IL-8-77 21 
secreted by host epithelial cells can be cleaved into more active, truncated forms. 22 
Collectively with IL-8-72, these truncated forms may recruit more neutrophils to 23 
the site of infections and also prime their activation which may contribute to the 24 
 29 
increased hyperactivity of neutrophils in periodontitis. Prolonged exposure to 1 
gingipains may trigger further degradation of IL-8-77 which may reduce 2 
chemotaxis and neutrophil priming, thus prolonging the inflammatory lesion.  3 
Gingipain structure from www.caspases.org 4 
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